Ingeborg Fischer, MD

Affiliations: 
 
Google:
"Ingeborg Fischer"
Mean distance: 16.97 (cluster 24)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cunliffe CH, Fischer I, Parag Y, et al. (2010) State-of-the-art pathology: new WHO classification, implications, and new developments. Neuroimaging Clinics of North America. 20: 259-71
Bollo RJ, Berliner JL, Fischer I, et al. (2009) Extraventricular subependymal giant cell tumor in a child with tuberous sclerosis complex. Journal of Neurosurgery. Pediatrics. 4: 85-90
Leesch W, Fischer I, Staudinger R, et al. (2009) Primary cerebral Whipple disease presenting as Klüver-Bucy syndrome. Archives of Neurology. 66: 130-1
Cunliffe CH, Fischer I, Monoky D, et al. (2009) Intracranial lesions mimicking neoplasms. Archives of Pathology & Laboratory Medicine. 133: 101-23
Cunliffe CH, Fischer I, Karajannis M, et al. (2009) Synchronous mixed germ cell tumor of the pineal gland and suprasellar region with a predominant angiomatous component: a diagnostic challenge. Journal of Neuro-Oncology. 93: 269-74
Narayana A, Kelly P, Golfinos J, et al. (2009) Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival. Journal of Neurosurgery. 110: 173-80
Narayana A, Golfinos JG, Fischer I, et al. (2008) Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma. International Journal of Radiation Oncology, Biology, Physics. 72: 383-9
Fischer I, Cunliffe CH, Bollo RJ, et al. (2008) High-grade glioma before and after treatment with radiation and Avastin: initial observations. Neuro-Oncology. 10: 700-8
Fischer I, Cunliffe C, Bollo RJ, et al. (2008) Glioma-like proliferation within tissues excised as tubers in patients with tuberous sclerosis complex. Acta Neuropathologica. 116: 67-77
Newcomb EW, Lukyanov Y, Schnee T, et al. (2007) The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivo. Anti-Cancer Drugs. 18: 875-82
See more...